Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 125-132

  Liu, Bin ^a   Jiang, Jian Wei ^b   Wilson, Belinda C ^a   Du, Lina ^b   Yang, San Nan ^c   Wang, Jiz Yuh ^c   Wu, Gen Cheng ^b   Cao, Xiao Ding ^b   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; NALOXONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG POTENCY; MALE; MICROGLIA; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, INBRED F344; SUBSTANTIA NIGRA;

EID: 0033810830     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Reactive nitrogen intermediates in human neuropathology: An overview
2. Speculations on the etiology of Parkonsin's disease
3. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
4. Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity
5. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrastriatal dopaminergic syste
6. The substantin nigra of the human brain II. Patterns of loss of dopamine-containing neurons in parkinson's disease
7. Magnetic resonance spectroscopic study of parkinsonism related to boxing
8. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
9. Trauma as an etiology of parkinsonism: A historical review of the concept
10. Pharmacological strategies in CNS trauma
11. A double blind trial of naloxone in the treatment of stroke
12. Progressive Parkinsonism in boxers
13. Human immunodeficiency virus and the brain
14. Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration?
15. Reversal of induced ischemic neurologic deficit in gerbil by the opiate antagonist naloxone
16. Studies in the (+)-morphinin series-5. Synthesis and biological properties of (+)-naloxone
17. Trauma as an etiologic agent in Parkinson disease
18. Oxidative stress and the pathogenesis of Parkinson's disease
19. Naloxone reversal of ischemic arrhythmia is stereospecific and suggesting role of endogenous opioid peptides in ischemic heart disease
20. High concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity
21. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia
22. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse
23. Microglia: A sensor for pathological events in the CNS
24. MPTP-induced parkinsonism in human and non-human primates - Clinical and experimental aspects
25. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
26. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β
27. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum
28. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-α-induced cell death
29. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
30. Inflammation in the CNS: Balance between immunological privilege and immune responses
31. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
32. The inflammatory response system of brain: Implications for therapy of Alzeimer and other neurodegenerative diseases
33. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures
34. Posttraumatic parkinsonism
35. Etiology and pathogenesis of parkinson's disease
36. Induction of NF-κB-like transcription factors in brain areas susceptible to kainate toxicity
37. Multiple sclerosis: Immune system molecule expression in the central nervous system
38. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
39. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients
40. Head trauma as a risk factor for Parkinson's disease
41. Functional plasticity of microglia: A review